Making the Case for Metabolic Surgery in Patients with Obesity and T2DM

Join Drs. Rachel Batterham, Carel W. Le Roux and Marco Bueter as they discuss the latest news for treatment of bariatric patients with type 2 diabetes mellitus.

Rachel Batterham Professor, Obesity, Diabetes and Endocrinology, University College London Hospital (UCLH); Head, UCLH/UCL National Institute of Health Research Biomedical Research Centre, London, United Kingdom
Rachel Batterham

MD, MBBS, PhD, FRCP

Professor, Obesity, Diabetes and Endocrinology, University College London Hospital (UCLH); Head, UCLH/UCL National Institute of Health Research Biomedical Research Centre, London, United Kingdom

MBChB, MSC, FRCP, FRCPath, PhD
Carel W Le Roux

MBChB, MSC, FRCP, FRCPath, PhD

Professor, Imperial College London,
London, United Kingdom; Chair of Experimental Pathology, Professor,University College Dublin, Dublin, Ireland

Professor, Head of Program for Bariatric and Metabolic Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerlan
Marco Bueter

MD, PhD

Professor, Head of Program for Bariatric and Metabolic Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerlan

 

Making the Case for Metabolic Surgery in Patients with Obesity and T2DM

 

Target Audience

This educational activity is intended for an international audience of non-US healthcare professionals, specifically diabetologists and endocrinologists, surgeons and primary care physicians involved in the treatment of patients with type 2 diabetes mellitus (T2DM).

Learning Objectives

Upon completion of this activity, participants will have increased knowledge regarding the:

• Science supporting bariatric interventions in the management of obesity and T2DM

• Clinical trial data for metabolic / bariatric surgery in the management of patients with obesity and T2DM

• Utility of metabolic / bariatric surgery vs the long-term risks of suboptimal treatment of obesity and T2DM

Purpose / Goal

The goal of this activity is to improve awareness of bariatric surgery vs pharmacotherapy in weight reduction and T2DM management, and in particular risk and benefits, and
clinical data.

Accreditation Statement

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

Commercial Support Acknowledgment

This educational activity is supported by an independent educational grant from Johnson & Johnson — Ethicon.

Johnson & Johnson — Ethicon products availiable on SurgStore

surgstore.ru bariatric surgery store

To learn more:

http://www.medscape.org/viewarticle/880113

Добавить комментарий

Ваш e-mail не будет опубликован. Обязательные поля помечены *